Sano Genetics | Latest News & Updates - Mar 11, 2025 Release

Sano Genetics released their first quarterly product update of 2025, featuring streamlined study setup, enhanced virtual waiting room, and scaled genetic testing capabilities...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Sano Genetics

🌎 sanogenetics.com

Sano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision medicine. The company offers an end-to-end precision medicine platform that integrates genetic testing, recruitment, and long-term patient engagement, streamlining clinical operations and enhancing the efficiency of clinical trials.


Sano Genetics - Latest News and Updates

  • Sano Genetics released their first quarterly product update of 2025, featuring streamlined study setup, enhanced virtual waiting room, and scaled genetic testing capabilities.
  • Paul Wicks, Vice President of Neuroscience at Sano Genetics, is attending a summit on MND and rare dementias in London with key industry players.
  • Sano Genetics reports that multiple genes, including FOXO3, influence longevity by regulating key biological processes like metabolism, DNA repair, and immune function.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.